BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 21382140)

  • 1. Local drug delivery for oral mucosal diseases: challenges and opportunities.
    Sankar V; Hearnden V; Hull K; Juras DV; Greenberg MS; Kerr AR; Lockhart PB; Patton LL; Porter S; Thornhill M
    Oral Dis; 2011 Apr; 17 Suppl 1():73-84. PubMed ID: 21382140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of topical drugs in treatment of oral mucosal diseases. A literature review.
    Sheikh S; Gupta D; Pallagatti S; Singla I; Gupta R; Goel V
    N Y State Dent J; 2013 Nov; 79(6):58-64. PubMed ID: 24600767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advanced drug delivery systems for local treatment of the oral cavity.
    Nguyen S; Hiorth M
    Ther Deliv; 2015; 6(5):595-608. PubMed ID: 26001175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New developments and opportunities in oral mucosal drug delivery for local and systemic disease.
    Hearnden V; Sankar V; Hull K; Juras DV; Greenberg M; Kerr AR; Lockhart PB; Patton LL; Porter S; Thornhill MH
    Adv Drug Deliv Rev; 2012 Jan; 64(1):16-28. PubMed ID: 21371513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in oral transmucosal drug delivery.
    Patel VF; Liu F; Brown MB
    J Control Release; 2011 Jul; 153(2):106-16. PubMed ID: 21300115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lectin-mediated drug delivery in the oral cavity.
    Smart JD
    Adv Drug Deliv Rev; 2004 Mar; 56(4):481-9. PubMed ID: 14969754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug delivery from the oral cavity: focus on a novel mechatronic delivery device.
    Scholz OA; Wolff A; Schumacher A; Giannola LI; Campisi G; Ciach T; Velten T
    Drug Discov Today; 2008 Mar; 13(5-6):247-53. PubMed ID: 18342801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pretreatment strategies for infection prevention in chemotherapy patients.
    Peterson DE
    NCI Monogr; 1990; (9):61-71. PubMed ID: 2111469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmaceutical approaches to colon targeted drug delivery systems.
    Chourasia MK; Jain SK
    J Pharm Pharm Sci; 2003; 6(1):33-66. PubMed ID: 12753729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcineurin inhibitors in oral medicine.
    Al Johani KA; Hegarty AM; Porter SR; Fedele S
    J Am Acad Dermatol; 2009 Nov; 61(5):829-40. PubMed ID: 19836643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chitosan delivery systems for the treatment of oral mucositis: in vitro and in vivo studies.
    Aksungur P; Sungur A; Unal S; Iskit AB; Squier CA; Senel S
    J Control Release; 2004 Aug; 98(2):269-79. PubMed ID: 15262418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral local drug delivery and new perspectives in oral drug formulation.
    Paderni C; Compilato D; Giannola LI; Campisi G
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2012 Sep; 114(3):e25-34. PubMed ID: 22771408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vesiculo-erosive oral mucosal disease--management with topical corticosteroids: (2) Protocols, monitoring of effects and adverse reactions, and the future.
    González-Moles MA; Scully C
    J Dent Res; 2005 Apr; 84(4):302-8. PubMed ID: 15790733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Orotransmucosal drug delivery systems: a review.
    Madhav NV; Shakya AK; Shakya P; Singh K
    J Control Release; 2009 Nov; 140(1):2-11. PubMed ID: 19665039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Buccal bioadhesive drug delivery--a promising option for orally less efficient drugs.
    Sudhakar Y; Kuotsu K; Bandyopadhyay AK
    J Control Release; 2006 Aug; 114(1):15-40. PubMed ID: 16828915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vesiculo-erosive oral mucosal disease--management with topical corticosteroids: (1) Fundamental principles and specific agents available.
    González-Moles MA; Scully C
    J Dent Res; 2005 Apr; 84(4):294-301. PubMed ID: 15790732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In situ delivery of corticosteroids for treatment of oral diseases.
    Caro V; Sutera FM; Giannola LI
    Ther Deliv; 2017 Oct; 8(10):899-914. PubMed ID: 28944742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regional variation in oral mucosal drug permeability.
    Kurosaki Y; Kimura T
    Crit Rev Ther Drug Carrier Syst; 2000; 17(5):467-508. PubMed ID: 11108157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Photochemical drug and gene delivery.
    Berg K; Selbo PK; Prasmickaite L; Høgset A
    Curr Opin Mol Ther; 2004 Jun; 6(3):279-87. PubMed ID: 15264430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.